Researchers Receive Grants from NCCN Oncology Research Program Funded through Onyx Pharmaceuticals

The NCCN Oncology Research Program (ORP) has awarded four research grants to investigators to scientifically evaluate and define clinical effectiveness of carfilzomib and oprozomib in non-Hodgkin lymphomas; The four grants are the result of funding from Onyx Pharmaceuticals. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) recently awarded four research grants to investigators following NCCN ORP Scientific Review Committee analysis of ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news